IMMUNOCAP THYRLOBULIN IMMUNOCAP— 510(k) K072661

Substantially Equivalent

Phadia US, Inc.

FDA 510(k) clearance K072661 for IMMUNOCAP THYRLOBULIN IMMUNOCAP, Substantially Equivalent on 2007-11-20. Applicant: Phadia US, Inc..

Clearance details

Applicant: Phadia US, Inc.
Product code: Code JNL
Advisory panel: Immunology
Date received: 2007-09-21
Decision date: 2007-11-20
Decision: Substantially Equivalent
Clearance type: Special
Location: Portage, MI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.